Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion type Assertion NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_head.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion description "[Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion evidence source_evidence_literature NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion SIO_000772 21943394 NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion wasDerivedFrom befree-2016 NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.
- NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_assertion wasGeneratedBy ECO_0000203 NP926022.RArxip1o9FwhMHndm2Wmve2a3pgagjRNPcC9cJo2ebrd4130_provenance.